India's Ranbaxy Labs reported a net loss of $153 million for the first quarter, hurt by currency fluctuations, a U.S. ban on some of its drugs and the global slowdown.
more
Friday, April 24, 2009
Subscribe to:
Post Comments (Atom)
The lastest news and observations about doing business in Asia.
No comments:
Post a Comment